Chiang Mai Ram Medical Business PCL (BKK:CMR)
1.490
+0.030 (2.05%)
Mar 7, 2025, 4:36 PM ICT
BKK:CMR Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 5,288 | 5,066 | 5,205 | 4,193 | 3,668 | Upgrade
|
Other Revenue | 65.41 | 78.72 | 64.48 | 51.08 | 48.97 | Upgrade
|
Revenue | 5,353 | 5,144 | 5,269 | 4,244 | 3,717 | Upgrade
|
Revenue Growth (YoY) | 4.06% | -2.37% | 24.17% | 14.17% | -6.26% | Upgrade
|
Cost of Revenue | 4,103 | 3,914 | 3,792 | 3,255 | 2,861 | Upgrade
|
Gross Profit | 1,250 | 1,230 | 1,477 | 988.66 | 855.73 | Upgrade
|
Selling, General & Admin | 837.24 | 712.34 | 657.84 | 528.56 | 537.41 | Upgrade
|
Operating Expenses | 837.24 | 712.34 | 657.84 | 528.56 | 537.41 | Upgrade
|
Operating Income | 412.74 | 518.13 | 819.27 | 460.1 | 318.31 | Upgrade
|
Interest Expense | -152.76 | -148.17 | -119.12 | -86.04 | -75.76 | Upgrade
|
Interest & Investment Income | 71.55 | 99.9 | 82.04 | 68.28 | 69.65 | Upgrade
|
Earnings From Equity Investments | 3.56 | 15.13 | 18.04 | 11.95 | 1.13 | Upgrade
|
EBT Excluding Unusual Items | 335.1 | 485 | 800.23 | 454.29 | 313.33 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 35.25 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | -0.22 | -2.23 | Upgrade
|
Pretax Income | 335.1 | 485 | 835.47 | 454.07 | 311.1 | Upgrade
|
Income Tax Expense | 93.38 | 102.14 | 151.31 | 77.89 | 67.52 | Upgrade
|
Earnings From Continuing Operations | 241.72 | 382.86 | 684.16 | 376.18 | 243.58 | Upgrade
|
Minority Interest in Earnings | -111.21 | -165.1 | -180.31 | -84.09 | -45.47 | Upgrade
|
Net Income | 130.51 | 217.75 | 503.86 | 292.09 | 198.11 | Upgrade
|
Net Income to Common | 130.51 | 217.75 | 503.86 | 292.09 | 198.11 | Upgrade
|
Net Income Growth | -40.07% | -56.78% | 72.50% | 47.44% | 25.33% | Upgrade
|
Shares Outstanding (Basic) | 4,071 | 4,046 | 4,023 | 4,023 | 4,023 | Upgrade
|
Shares Outstanding (Diluted) | 4,071 | 4,046 | 4,023 | 4,023 | 4,023 | Upgrade
|
Shares Change (YoY) | 0.62% | 0.57% | - | - | - | Upgrade
|
EPS (Basic) | 0.03 | 0.05 | 0.13 | 0.07 | 0.05 | Upgrade
|
EPS (Diluted) | 0.03 | 0.05 | 0.13 | 0.07 | 0.05 | Upgrade
|
EPS Growth | -40.44% | -57.03% | 72.50% | 47.44% | 25.33% | Upgrade
|
Free Cash Flow | 626.08 | 642.64 | 749.9 | -235.51 | -779.03 | Upgrade
|
Free Cash Flow Per Share | 0.15 | 0.16 | 0.19 | -0.06 | -0.19 | Upgrade
|
Dividend Per Share | 0.050 | 0.055 | 0.066 | 0.065 | 0.052 | Upgrade
|
Dividend Growth | -9.09% | -16.67% | 1.54% | 25.00% | -11.11% | Upgrade
|
Gross Margin | 23.35% | 23.92% | 28.03% | 23.30% | 23.02% | Upgrade
|
Operating Margin | 7.71% | 10.07% | 15.55% | 10.84% | 8.56% | Upgrade
|
Profit Margin | 2.44% | 4.23% | 9.56% | 6.88% | 5.33% | Upgrade
|
Free Cash Flow Margin | 11.70% | 12.49% | 14.23% | -5.55% | -20.96% | Upgrade
|
EBITDA | 883.42 | 1,008 | 1,283 | 802.2 | 591.87 | Upgrade
|
EBITDA Margin | 16.50% | 19.59% | 24.34% | 18.90% | 15.92% | Upgrade
|
D&A For EBITDA | 470.68 | 489.71 | 463.48 | 342.11 | 273.56 | Upgrade
|
EBIT | 412.74 | 518.13 | 819.27 | 460.1 | 318.31 | Upgrade
|
EBIT Margin | 7.71% | 10.07% | 15.55% | 10.84% | 8.56% | Upgrade
|
Effective Tax Rate | 27.87% | 21.06% | 18.11% | 17.15% | 21.70% | Upgrade
|
Revenue as Reported | 5,425 | 5,244 | 5,387 | 4,312 | 3,784 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.